Clinical Trial Update: A Study of Multiple Intravitreal Injection TK001 in Patients With Neovascular Age-related Macular Degeneration [Phase 1]

View source ↗

Summary

Phase 1 study evaluating multiple intravitreal injections of TK001 for neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• TK001

Snippet

Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd | Conditions: Neovascular Age-Related Macular Degeneration | Phase 1 | Status: UNKNOWN